September 29th 2025, 8:00pm
Tamara Mobley shares how persistent back pain led to her myeloma diagnosis and why she now raises awareness to help others recognize subtle warning signs.
September 29th 2025, 7:00pm
Patients with prostate cancer can position themselves to receive the best care possible by being seen by a multidisciplinary team of healthcare providers.
September 29th 2025, 5:00pm
After surviving testicular cancer, I learned to let go of envy, live in the moment, and embrace gratitude by staying true to who I am.
September 29th 2025, 4:00pm
Dr. Sandip Patel discusses findings from a real-world study of biomarker testing in early-stage resected non-small cell lung cancer in the U.S.
September 29th 2025, 3:00pm
Enhertu significantly improved invasive disease-free survival when compared with Kadcyla in high-risk HER2-positive early breast cancer.
September 29th 2025, 1:00pm
Dr. Patrick J. Hensley shares the treatment landscape of non-muscle-invasive bladder, as well as how individual risk factors can alter treatment options.
September 28th 2025, 6:00pm
Dr. Patrick Wen discussed with CURE how Modeyso treats diffuse midline glioma, and what unmet needs remain for patients now that the therapy is available.
September 28th 2025, 2:00pm
I faced breast cancer and unexpected body changes with resilience and humor, learning to adapt and find strength in the process.
September 27th 2025, 6:00pm
Dr. Alexander Spira explained the difference between a clinical trial and a real-world study in a CURE interview for patients with lung cancer.
September 27th 2025, 2:00pm
Cancer during pregnancy is rare but increasingly recognized as maternal age rises and non-invasive prenatal testing becomes more common.
Basal Cell Carcinoma Basics, From Diagnosis to Treatment
Stage 2 Cervical Cancer: Key Facts and Updates for Patients
HR+/HER2– Breast Cancer: Diagnosis and Treatment Guide
So You Want To Be A Cancer Advocate